People who are genetically equipped to stop hepatitis C viruses from turning off a type of interferon generally have a robust antiviral response. Findings on the mechanisms governing this ability suggest new avenues for treatment research.


People who are genetically equipped to stop hepatitis C viruses from turning off a type of interferon generally have a robust antiviral response. Findings on the mechanisms governing this ability suggest new avenues for treatment research.